V1RE11 activators comprise a chemical class of compounds that can influence the signaling pathways of the V1RE11 protein, a member of the G protein-coupled receptor (GPCR) family. These activators encompass a diverse array of chemical entities, each with a unique mode of action on the cellular mechanisms that can engage V1RE11. Some compounds in this class function by increasing the intracellular concentration of second messengers like cAMP, which plays a pivotal role in the signaling cascade of GPCRs. By elevating cAMP levels, these activators can enhance the receptor's signaling efficiency. Other molecules in this class are designed to modulate protein kinase activity, which can subsequently lead to the phosphorylation of proteins associated with V1RE11 signaling. This phosphorylation can alter the receptor's conformation or its interaction with other cellular components, thereby modulating its activity.
Additionally, the chemical class of V1RE11 activators includes compounds that alter intracellular calcium levels, either by sequestering calcium ions or facilitating their influx into the cell. Calcium ions serve as crucial secondary messengers in GPCR signaling and, therefore, fluctuations in calcium concentrations can have a significant impact on V1RE11 activity. Some activators target specific proteins involved in the breakdown or synthesis of signaling molecules, thereby affecting the receptor's signaling pathway. These modulators either prevent the degradation of signaling molecules, allowing them to exert their effects for a prolonged period, or inhibit enzymes that participate in the signaling cascade, thus altering the receptor's response. Collectively, the chemicals within the V1RE11 activators class act on various components of the cellular machinery to regulate the activity of this receptor without directly binding to the receptor itself.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which could activate Vmn1r66 by phosphorylating related proteins and potentially altering receptor activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a phosphodiesterase inhibitor that prevents the breakdown of cAMP, which could result in enhanced signaling through Vmn1r66. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which could activate Vmn1r66 by affecting calcium-dependent signaling pathways. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
BAPTA-AM is a calcium chelator that could activate Vmn1r66 by modulating intracellular calcium levels and affecting downstream signaling. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Pertussis toxin inhibits G(i/o) proteins and could alter Vmn1r66 signaling by changing the regulatory context of the receptor’s activity. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine, as a phosphodiesterase inhibitor, could activate Vmn1r66 by raising cAMP levels within the cell, affecting the receptor’s signaling. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
2-ApB modulates IP3 receptors and could activate Vmn1r66 by altering calcium signaling pathways in the cell. | ||||||